Disease Burden of Chemotherapy and Chemoimmunotherapy Treatment of Relapse/Refractory Mantle Cell Leukemia (Rrmcl) Patients in China
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.100
https://www.valueinhealthjournal.com/article/S1098-3015(18)32457-4/fulltext
Title :
Disease Burden of Chemotherapy and Chemoimmunotherapy Treatment of Relapse/Refractory Mantle Cell Leukemia (Rrmcl) Patients in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32457-4&doi=10.1016/j.jval.2018.07.100
First page :
Section Title :
Open access? :
No
Section Order :
113